Anna Kuranova

Anna Kuranova


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JRJerrald L Rector
Jerrald L Rector
AKAnna Kuranova
Anna Kuranova
MRMarcel Olde Rikkert
Marcel Olde Rikkert
HGHarry van Goor
Harry van Goor
RMRené Melis
René Melis
SBSebastian JH Bredie
Sebastian JH Bredie
Background/Objectives: The effective management of acute illnesses like COVID-19 requires tools to dynamically assess a patient’s resilience to health stressors. This study evaluates novel dynamic biomarkers from continuous blood oxygen saturation (SpO2) monitoring, exploring their association with patient outcomes to support clinical decision making. Methods: We examined 200 hospital admissions from 181 adults diagnosed with COVID-19. Two dynamic biomarkers reflecting the homeostatic regulation efficiency of SpO2 were developed to assess their association with adverse hospital outcomes, specifically ICU admission or death, using binary logistic regressions. The resilience exponent α recorded the relative frequency of prolonged SpO2 declines, while O2 challenges quantified the dynamic response to changes in O2 supplementation. Results: Increased resilience exponent α corresponded to decreased odds of adverse outcomes (OR [95% CI] = 0.59 [0.37–0.93], p = 0.03). Larger SpO2 increases in response to O2 supplementation were associated with increased odds of adverse outcomes (OR [95% CI] = 1.40 [1.04–1.83], p = 0.03). Additionally, the number of O2 supplementation increases (OR [95% CI] = 2.91 [1.90–4.49]) and decreases (OR [95% CI] = 0.33 [0.20–0.55]) during hospitalization were independently linked to poorer and improved outcomes, respectively (both p < 0.001). Conclusions: The resilience exponent α and the O2 challenge response provide insights into the dynamic regulation of SpO2, reflecting physical resilience in COVID-19 patients. Continuous SpO2 monitoring in acute care settings could support more informed clinical decisions during patient management.